Detalles de la búsqueda
1.
Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.
PLoS Pathog
; 15(4): e1007721, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31009499
2.
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.
J Infect Dis
; 213(9): 1428-35, 2016 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26704615
3.
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
J Infect Dis
; 211(5): 801-10, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25293368
4.
Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial.
Clin Infect Dis
; 60(11): e80-9, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25673560
5.
Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.
J Infect Dis
; 210(9): 1419-30, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24864125
6.
Heterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age.
J Infect Dis
; 210(11): 1800-10, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24973461
7.
Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.
J Infect Dis
; 210(4): 545-57, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652494
8.
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.
J Infect Dis
; 207(5): 700-8, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23225894
9.
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
BMC Infect Dis
; 13: 435, 2013 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041010
10.
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19.
NPJ Vaccines
; 6(1): 128, 2021 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711846
11.
Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system.
Influenza Other Respir Viruses
; 15(1): 110-120, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889792
12.
Historical Analysis of the Risk of Hepatitis E and Its Complications in Pregnant Women in Nepal, 1996-1998.
Am J Trop Med Hyg
; 105(2): 440-448, 2021 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125701
13.
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.
Pediatr Infect Dis J
; 40(9): e333-e339, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34285165
14.
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Vaccine
; 39(30): 4013-4024, 2021 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119350
15.
Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005.
Clin Infect Dis
; 50(8): 1135-43, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20205587
16.
Safety and efficacy of a recombinant hepatitis E vaccine.
N Engl J Med
; 356(9): 895-903, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17329696
17.
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study.
Am J Trop Med Hyg
; 102(5): 951-954, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32124728
18.
Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study.
Am J Trop Med Hyg
; 103(1): 132-141, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342848
19.
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques.
PLoS Negl Trop Dis
; 14(4): e0008191, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32267846
20.
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
Hum Vaccin
; 5(1): 33-40, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18670195